Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:26187391n
Noun Concept
IT
No term available
EN
Brexucabtagene autoleucel, sold under the brand name Tecartus, is a cell-based gene therapy medication for the treatment of mantle cell lymphoma and acute lymphoblastic leukemia. Wikipedia
Relations
Sources
IS A
terapia genica

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License